Bringing a cosmetic product from initial concept to retail shelf is a structured, multi-stage process governed by scientific rigour, regulatory frameworks, and manufacturing precision. Every stage produces data — formulation records, stability results, safety assessments, regulatory filings, batch documentation — and the ability to manage that data in a connected, traceable system determines how efficiently a product reaches market.
This article outlines the seven stages of cosmetic product development, the requirements at each stage, and where purpose-built software transforms what has traditionally been a fragmented, document-heavy process into a streamlined, auditable workflow.
1. Concept and Market Research
Every product begins with an opportunity: a gap in the market, a new active ingredient, an emerging consumer trend, or a specific brief from a brand client. During this phase, R&D teams define the product concept — target consumer profile, desired claims (moisturising, anti-ageing, SPF protection), texture and sensory targets, price positioning, and regulatory scope (which markets will the product be sold in).
Ingredient trend analysis plays a critical role. Teams evaluate new raw materials entering the market, assess their regulatory status across target jurisdictions, and identify ingredients that align with the product brief. AI-powered platforms accelerate this stage by surfacing ingredient suggestions based on target claims, regulatory constraints, and formulation compatibility — drawing on datasets of 100,000+ raw material profiles rather than relying solely on the formulator's memory and supplier catalogues.
2. Formulation and Prototyping
Formulation is the core scientific stage. Chemists create initial formulas, select raw materials with appropriate INCI (International Nomenclature of Cosmetic Ingredients) designations, and iterate through multiple prototypes. Each version is tested for texture, stability indicators, pH, viscosity, colour, and fragrance compatibility.
This stage demands rigorous version control. A single product may pass through dozens of formula iterations before a candidate is selected for formal testing. Labify® Beauté manages this complexity through hierarchical organisation — brands → projects → formulas → versions → tests — ensuring every iteration is recorded, comparable, and traceable back to its raw material inputs. Automatic INCI list generation eliminates the manual, error-prone process of compiling ingredient declarations across multiple formulation changes.
3. Stability Testing
Once a candidate formula is identified, it must demonstrate physical and chemical stability under defined conditions. Accelerated stability studies expose the product to elevated temperatures (typically 40 °C / 75% relative humidity), freeze-thaw cycles, and light exposure over periods ranging from 4 weeks to 3 months. Real-time stability studies run concurrently at ambient conditions over 12 to 24 months.
The data generated — appearance, odour, pH, viscosity, microbial counts, preservative efficacy — must be captured at scheduled intervals, compared against acceptance criteria, and retained as part of the product dossier. Software that manages stability study scheduling, automates data capture reminders, and stores results alongside the originating formula version eliminates the spreadsheet chaos that plagues many laboratories.
4. Safety Assessment
Before any cosmetic product can be placed on the EU market, it requires a formal safety assessment conducted by a qualified safety assessor. Under EU Cosmetics Regulation 1223/2009, this assessment produces a Cosmetic Product Safety Report (CPSR) comprising two parts: Part A (product safety information) and Part B (the safety assessor's conclusions).
Central to the safety assessment is the Margin of Safety (MOS) calculation for each ingredient. The MOS evaluates systemic exposure by comparing the No Observed Adverse Effect Level (NOAEL) to estimated human exposure, factoring in dermal absorption, product use frequency, and body weight — calculated separately for adults and, where applicable, children under three. Software automates MOS calculations across all ingredients in a formula, flags substances that fail to meet the accepted threshold (typically MOS ≥ 100), and identifies allergens and restricted substances — tasks that, performed manually, are both time-consuming and vulnerable to human error.
5. Regulatory Filing
With a validated formula and completed safety assessment, the product must be formally notified before it can be sold. In the EU, this means registering the product on the Cosmetic Products Notification Portal (CPNP) and compiling the complete Product Information File (PIF). The PIF includes the formula with quantitative composition, the CPSR, manufacturing method descriptions, proof of claimed effects, and animal testing declarations.
The cosmetic dossier — the comprehensive technical and regulatory file for the product — is generated from data that already exists in the formulation and testing stages. Labify® Beauté automates dossier generation directly from formulation data, safety assessment results, and stability records already present in the integrated platform, eliminating double-entry and ensuring that the regulatory file is always synchronised with the latest approved formula version.
6. Manufacturing Scale-Up
Transitioning from a laboratory bench formula to production-scale manufacturing introduces a new category of complexity. Ingredient quantities must be recalculated for batch sizes that may be hundreds or thousands of times larger than the lab prototype. Raw materials must be procured, received, quarantined, tested, and released. Manufacturing orders must be generated with precise ingredient lists, equipment assignments, and production scheduling.
Labify® Factory manages this stage with full ERP (Enterprise Resource Planning) capabilities purpose-built for cosmetics and fragrance manufacturing. It handles manufacturing order generation, raw material purchase orders, warehouse management with delivery note handling, batch allocation (manual or automatic), and full raw material traceability from supplier certificate of analysis through to finished product batch record. The automatic MOS recalculation at batch level ensures that manufacturing substitutions or concentration adjustments do not compromise product safety.
7. Market Launch and Post-Market Surveillance
The final stage encompasses packaging order management, final quality release, delivery documentation, and the product entering distribution. However, regulatory responsibility does not end at launch. EU Cosmetics Regulation 1223/2009 requires ongoing post-market monitoring — tracking adverse event reports, monitoring regulatory changes that may affect ingredient legality or concentration limits, and maintaining the PIF as a living document updated with any formula or manufacturing changes.
Software maintains the complete audit trail from concept through to post-market phase, ensuring that any question — from a regulatory authority, a retailer, or an internal quality team — can be answered with traceable, timestamped records linking the finished product back through every stage of its development.
Why an Integrated Platform Matters
The seven stages described above are not isolated activities. Formulation data feeds safety assessment. Safety assessment feeds regulatory filing. Regulatory approval triggers manufacturing. Manufacturing references the exact approved formula. Each handoff between stages is a point where data integrity can fail — a transcription error, an outdated formula version, a missed regulatory update.
A vertically integrated platform that connects all seven stages in a single data environment eliminates these failure points. When the formulator updates a formula version, the stability study links to the correct iteration. When the safety assessor calculates MOS values, they draw directly from the quantitative composition in the system. When manufacturing generates a batch order, it references the regulatory-approved formula — not a PDF copy that may be out of date.
This is the fundamental argument for purpose-built cosmetics software over generic project management, spreadsheet, or horizontal ERP tools: the domain logic — INCI nomenclature, MOS calculations, CPNP notification requirements, stability study protocols, raw material traceability — must be native to the system, not retrofitted onto a platform that was designed for a different industry.